Tower Research Capital LLC (Trc) Hoth Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.36 - $9.25 $1,094 - $28,120	3,040 Added 22.77%	16,388 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.38 - $1.05 $2,716 - $7,505	7,148 Added 115.29%	13,348 $6,000
Q1 2022 May 12, 2022	BUY	$0.52 - $1.3 $3,224 - $8,060	6,200 New	6,200 $4,000
Q2 2021 Aug 16, 2021	SELL	$1.31 - $2.14 $144 - $235	-110 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.85 - $3.04 $7,427 - $12,205	-4,015 Reduced 97.33%	110 $0
Q4 2020 Feb 16, 2021	BUY	$1.58 - $2.37 $4,345 - $6,517	2,750 Added 200.0%	4,125 $10,000
Q3 2020 Nov 16, 2020	BUY	$1.86 - $3.15 $2,557 - $4,331	1,375 New	1,375 $3,000
Q2 2019 Aug 13, 2019	SELL	$4.76 - $8.1 $3,117 - $5,305	-655 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$5.15 - $8.53 $3,373 - $5,587	655 New	655 $3,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.11M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.